UNSPSC 51362200: Hypnotic carboxylic acids

Hypnotic drugs made from organic compounds containing the carboxy group (-COOH).

UNSPSC 51362200 Hypnotic carboxylic acids is a Class code that state and local governments are using to procure naloxone, safe drug deactivation systems, and generic multi-source pharmaceuticals and over-the-counter products through both direct purchase and cooperative purchasing arrangements. The solicitations under this code reflect community health and pharmacy benefit initiatives rather than the abstract pharmaceutical chemical classification the code name suggests. Issuing bodies include county health departments, state health and human services agencies, and multistate cooperative purchasing alliances. The procurement mix spans direct commodity purchases for emergency response and harm reduction (naloxone kits and drug deactivation systems), exploratory market research for pharmacy benefit program redesign (direct-to-manufacturer prescription programs), and large-scale cooperative pharmaceutical supply contracts serving multiple state and local jurisdictions.

Recent activity appears concentrated in Florida, Texas, and Minnesota. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, with a response deadline of July 26, 2023 (note: the posted date and due date suggest a documentation error in the source). The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, requesting vendor information on direct-to-manufacturer prescription program capabilities for state pharmacy benefit management, functioning as preliminary market research before formal RFP issuance. The Minnesota Department of Administration's Office of State Procurement, administering the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), issued RFP S1070000015802 on January 20, 2026, for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026, serving participating state and local government facilities across Minnesota and Oregon through three authorized wholesalers.